Cargando…
Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer
INTRODUCTION: Ovarian cancer recurs in most High Grade Serous Ovarian Cancer (HGSOC) patients, including initial responders, after standard of care. To improve patient survival, we need to identify and understand the factors contributing to early or late recurrence and therapeutically target these m...
Autores principales: | Adzibolosu, Nicholas, Alvero, Ayesha B., Ali-Fehmi, Rouba, Gogoi, Radhika, Corey, Logan, Tedja, Roslyn, Chehade, Hussein, Gogoi, Vir, Morris, Robert, Anderson, Matthew, Vitko, Julie, Lam, Clarissa, Craig, Douglas B., Draghici, Sorin, Rutherford, Thomas, Mor, Gil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331425/ https://www.ncbi.nlm.nih.gov/pubmed/37435088 http://dx.doi.org/10.3389/fimmu.2023.1204148 |
Ejemplares similares
-
Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression
por: Chehade, Hussein, et al.
Publicado: (2022) -
Generation of Stable Epithelial–Mesenchymal Hybrid Cancer Cells with Tumorigenic Potential
por: Tedja, Roslyn, et al.
Publicado: (2023) -
A Novel Role of Connective Tissue Growth Factor in the Regulation of the Epithelial Phenotype
por: Gogoi, Radhika P., et al.
Publicado: (2023) -
MNRR1 is a driver of ovarian cancer progression
por: Chehade, Hussein, et al.
Publicado: (2023) -
Adipose-derived exosomal miR-421 targets CBX7 and promotes metastatic potential in ovarian cancer cells
por: Zhang, Yi, et al.
Publicado: (2023)